Sharath Chandra

• Lead the commercial analytics strategy for a blockbuster oncology brand, managing a team of six associates to drive brand growth and operational excellence.
• Spearhead a multi-vendor EHR integration initiative, consolidating real-world data into standardised, analysis-ready assets to enable faster, insight-driven decision making.
• Architect and implement super stacking frameworks, and build analytical datamarts, reducing time-to-insight and enhancing GTM readiness across brands.
• Leverage deep expertise in Anonymous Patient-Level Data (APLD) to guide advanced patient analytics initiatives, including DOT (Duration of Therapy), adherence, persistence, and complex longitudinal patient journey studies.
• Operate as a hands-on leader, bridging technical data development with strategic commercial applications to support brand launches, targeting, segmentation, and field force optimisation.
• Collaborate cross-functionally with Data Science, IT, Market Access, CI, Forecasting and Field Excellence teams to ensure data assets directly align with brand strategies

Key Responsibilities:

• Worked as a Manager in Business Analytics team supporting Novartis' US Respiratory and Cardiovascular (CRM) Franchise
• Playing an integral part in driving the projects forward, contributing expertise to support their progress
• Instrumental in conducting detailed patient-level analysis by leveraging IQVIA APLD data and by employing advanced methodologies to delve into individual patient data and extract valuable insights.
• Acted as the Engagement lead for the Novartis' Respiratory Portfolio supporting US stakeholders
• Throughout my two-year tenure as Manager, I spearheaded multiple projects utilizing diverse datasets including APLD, IQVIA Sub-national (DDD, Xponent, and Plantrak), as well as National Datasets (SMART), Syneos, Pharmaforce, and Evaluate Pharma.
• Managed and mentored 6 associates with their trainings, upskilling, validations and execution
• Worked with multiple stakeholders for requirement gathering, insights sharing and project execution
• Collaborated with cross functional teams, as Brand SME, on initiatives such as Forecasting, FF execution and others

Key Projects:

• Built multiple opportunity analysis by investigating patient level data to identify trends and patterns, and provide insights to US stakeholders
• Experience working on anonymous patient level data - Key analysis include Leqvio opportunity among statin patients, persistency, source of business, event to treatment etc.
• Identified potential risk patients based on specific criteria, diagnoses, procedures, comorbidities and factors that could categorize them into the risk group
• Created a HCP behavioral model identifying various attributes and built a tracker highlighting their prescribing behavior regularly
• Prepared a launch tracker for one of the competitor, by using existing analogs and estimated its launch uptake
• Created deep-dive analysis on launch indication, and share among existing indications and market opportunity
• Examined the call activity and business contribution of brand within the context of Face-to-face and virtual field force

Highlights:

• Built a PPT Dashboard from scratch for CFO and Senior VP, Finance which gives overview of current Novartis' position and forecast by leveraging IQVIA, Evaluate Pharma and DRG datasets
• Specified the role and contribution of virtual salesforce and helped stakeholders in effective sizing of Field Force
• Contributed and directed team in building an effective Field Force tracker (SPARKLE) which includes indication-wise volume achieved by the sales representatives

Highlights:

• Responsible for analyzing and writing deep-dive articles for pharmaceutical deals (mergers, acquisitions, licensing, research and development agreements) across the pharmaceutical industry
• Creating company profile, portfolio analysis, strategy (Corporate, geography, and therapy area strategy) and outlook of the companies including growth drivers, resistors and impactors
• Liaising with stakeholders on an ongoing basis for driving and participating in existing product development, enhancement, and process improvement initiatives and new product development ideas
• Knowledge on multiple in-house databases including MIDAS-PADDS, Analytics Link, Pipeline Link, Forecast Link, and Pharma Deals
  

Highlights:

• Expert in writing disease market analysis: Authored ‘Anti-inflammatory Market Analysis and Forecast’ covering Arthritis, Asthma, COPD, Multiple Sclerosis, Psoriasis and Inflammatory Bowel diseases on a global level; Authored Multi-Country Market Assessment of Acute Myeloid Leukemia, Acute Lymphoid Leukemia, and Myeloproliferative Neoplasms.
• Authored CountryFocus reports for Indonesia, South Korea, Saudi Arabia, Philippines, China, UAE, Israel, Russia, Germany, Poland, Canada and Egypt with emphasis on the Healthcare, Regulatory and Reimbursement Landscape and ensuring quality of the reports and uploading of reports on the CMS site and to the Report Store.
• Experience in writing pharma reports by building data forecast models (epidemiology-based, drug-based, and disease-based) Validation of forecasted model with drug share and market analysis by data triangulation